Paracetamol / Diclofenac potassium / Serratiopeptidase
Non-opioid analgesic / antipyretic
What it is used for
Therapeutic use is agent- and indication-specific within the class (Non-opioid analgesic / antipyretic). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC.
Warnings
[From component Paracetamol] Risk of severe hepatotoxicity in overdose. Chronic high-dose use, malnutrition, enzyme-inducing drugs, and alcohol increase risk. Check total daily intake from all sources.
Possible side effects
[Paracetamol] Rare at therapeutic doses. Serious: acute liver failure in overdose, rare severe skin reactions (SJS/TEN/AGEP). [Diclofenac] [From component Diclofenac] GIT disturbances, GIT ulceration, headache, dizziness, vertigo, tinnitus, taste alteration, blood dyscrasia, renal, hepatic disorders. [Serratiopeptidase] [From component Diclofenac] GIT disturbances, GIT ulceration, headache, dizziness, vertigo, tinnitus, taste alteration, blood dyscrasia, renal, hepatic disorders.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.